WD repeat domain 76 predicts poor prognosis in lower grade glioma and provides an original target for immunotherapy

ConclusionsThis study shows for the first time the diagnostic and prognostic value ofWDR76 in LGG and provides a novel personalized biomarker for future targeted therapy and immunotherapy. Thus,WDR76 may significantly improve the prognosis of patients with LGG.
Source: European Journal of Medical Research - Category: Research Source Type: research